[go: up one dir, main page]

MA31456B1 - Complexes de fer et de derives d'hydrates de carbone solubles dans l'eau, leur fabrication et medicaments les contenant - Google Patents

Complexes de fer et de derives d'hydrates de carbone solubles dans l'eau, leur fabrication et medicaments les contenant

Info

Publication number
MA31456B1
MA31456B1 MA32435A MA32435A MA31456B1 MA 31456 B1 MA31456 B1 MA 31456B1 MA 32435 A MA32435 A MA 32435A MA 32435 A MA32435 A MA 32435A MA 31456 B1 MA31456 B1 MA 31456B1
Authority
MA
Morocco
Prior art keywords
iron
drugs
complex
derivatives
mixture
Prior art date
Application number
MA32435A
Other languages
Arabic (ar)
English (en)
Inventor
Stefan Reim
Erik Philipp
Felix Funk
Hans-Martin Müller
Peter Geisser
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38287550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31456(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of MA31456B1 publication Critical patent/MA31456B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un complexe de fer et de dérivés d'hydrates de carbone, pouvant être obtenu à partir d'une solution saline de fer(iii) aqueuse et d'une solution aqueuse du produit de l'oxydation, et par dérivatisation consécutive d'une ou plusieurs maltodextrines avec une solution d'hypochlorite aqueuse à un ph alcalin. En cas d'utilisation d'une maltodextrine, l'équivalent dextrose de celle-ci se situe entre 5 et 20, et en cas d'utilisation d'un mélange de plusieurs maltodextrines, l'équivalent dextrose du mélange se situe entre 5 et 20 et l'équivalent dextrose de chaque maltodextrine contenue dans le mélange se situe entre 2 et 40, la dérivatisation consécutive étant réalisée avec un réactif adéquat. L'invention concerne également des procédés de fabrication de ces complexes et des médicaments de prophylaxie et de traitement d'états de carences en fer.
MA32435A 2007-05-29 2009-12-21 Complexes de fer et de derives d'hydrates de carbone solubles dans l'eau, leur fabrication et medicaments les contenant MA31456B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109081A EP1997833A1 (fr) 2007-05-29 2007-05-29 Complexes fer-dérivé d'hydrate de carbone hydrosolubles, leur fabrication et médicaments contenants ces complexes
PCT/EP2008/056276 WO2008145586A1 (fr) 2007-05-29 2008-05-21 Complexes de fer et de dérivés d'hydrates de carbone solubles dans l'eau, leur fabrication et médicaments les contenant

Publications (1)

Publication Number Publication Date
MA31456B1 true MA31456B1 (fr) 2010-06-01

Family

ID=38287550

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32435A MA31456B1 (fr) 2007-05-29 2009-12-21 Complexes de fer et de derives d'hydrates de carbone solubles dans l'eau, leur fabrication et medicaments les contenant

Country Status (26)

Country Link
US (1) US8263577B2 (fr)
EP (2) EP1997833A1 (fr)
JP (1) JP5259700B2 (fr)
KR (1) KR101168085B1 (fr)
CN (1) CN101679530B (fr)
AR (1) AR065997A1 (fr)
AU (1) AU2008257683B2 (fr)
BR (1) BRPI0811985B8 (fr)
CA (1) CA2682587C (fr)
CL (1) CL2008001549A1 (fr)
CO (1) CO6241161A2 (fr)
ES (1) ES2547304T3 (fr)
GT (1) GT200900308A (fr)
IL (1) IL201294A (fr)
MA (1) MA31456B1 (fr)
MX (1) MX2009012889A (fr)
MY (1) MY158004A (fr)
NZ (1) NZ581487A (fr)
PE (1) PE20090317A1 (fr)
PL (1) PL2148890T3 (fr)
PT (1) PT2148890E (fr)
RU (1) RU2441881C2 (fr)
TN (1) TN2009000443A1 (fr)
TW (1) TWI372621B (fr)
WO (1) WO2008145586A1 (fr)
ZA (1) ZA200907672B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
WO2007081744A2 (fr) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Méthodes et compositions pour l'administration de fer
HUE030866T2 (en) 2009-03-25 2017-06-28 Pharmacosmos Holding As A stable iron oligosaccharide compound
US20120214986A1 (en) * 2009-11-04 2012-08-23 Symed Labs Limited Process for the preparation of iron (iii) carboxymaltose complex
ES2660202T3 (es) 2010-03-23 2018-03-21 Vifor (International) Ag Compuestos del complejo Fe (iii) para el tratamiento y la profilaxis de los síntomas de deficiencia de hierro y las anemias ferropénicas
CN101891832B (zh) * 2010-07-22 2012-01-04 山东农业大学 一种无碱均相生产氧化淀粉方法
WO2012104204A1 (fr) 2011-01-31 2012-08-09 Vifor (International) Ag Composés à base d'un complexe de fer-hydrate de carbone pour la thérapie intraveineuse du paludisme
WO2013056085A1 (fr) * 2011-10-13 2013-04-18 Vidasym, Inc. Composition de fibre de fer, sa préparation et ses utilisations
CN109497565B (zh) 2013-03-08 2021-10-26 上海礼邦医药科技有限公司 金属离子-功能性纤维组分络合物组合物、其制备及用途
US9370202B2 (en) * 2013-03-15 2016-06-21 LG Bionano, LLC Encapsulated metal ion nanoclusters
CN107438626A (zh) * 2015-03-23 2017-12-05 苏文生命科学有限公司 水溶性三价铁碳水化合物复合物的制备
CN105125577B (zh) * 2015-07-29 2018-05-18 南京生命能科技开发有限公司 一种稳定的糖-铁复合物及其制备方法
CN105520955B (zh) * 2015-12-21 2018-05-11 南京生命能科技开发有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
WO2019193608A1 (fr) * 2018-04-05 2019-10-10 Msn Laboratories Private Limited, R&D Center Procédé amélioré pour la préparation de carboxymaltose ferrique
CN115368477B (zh) * 2021-05-21 2023-05-02 武汉科福新药有限责任公司 高得率、高含铁量的羧基麦芽糖铁的制备方法
CN115368478B (zh) * 2021-05-21 2023-07-04 武汉科福新药有限责任公司 一种羧基麦芽糖铁的制备方法
CN115322265A (zh) * 2022-08-29 2022-11-11 滨州学院 一种羧基麦芽糖控制性氧化与纯化工艺
WO2026017897A1 (fr) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Supplémentation en fer dans des troubles affectifs et/ou un trouble de stress post-traumatique (ptsd) et/ou des maladies dépendantes de la sérotonine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (fr) 2005-08-25 2007-02-28 Vifor (International) Ag Complexes de fer III pour traiter les manques de fer en patients avec la maladie intestinale inflammatoire

Also Published As

Publication number Publication date
MX2009012889A (es) 2009-12-10
IL201294A0 (en) 2010-05-31
EP1997833A1 (fr) 2008-12-03
AU2008257683B2 (en) 2012-06-21
ZA200907672B (en) 2010-07-28
JP5259700B2 (ja) 2013-08-07
JP2010528166A (ja) 2010-08-19
GT200900308A (es) 2011-09-06
BRPI0811985B8 (pt) 2021-05-25
PL2148890T3 (pl) 2016-01-29
AR065997A1 (es) 2009-07-15
BRPI0811985A2 (pt) 2014-11-18
WO2008145586A1 (fr) 2008-12-04
IL201294A (en) 2013-06-27
ES2547304T3 (es) 2015-10-05
KR101168085B1 (ko) 2012-07-24
KR20100010502A (ko) 2010-02-01
HK1140219A1 (en) 2010-10-08
TWI372621B (en) 2012-09-21
AU2008257683A1 (en) 2008-12-04
CN101679530A (zh) 2010-03-24
PT2148890E (pt) 2015-10-15
BRPI0811985B1 (pt) 2020-04-07
MY158004A (en) 2016-08-30
RU2441881C2 (ru) 2012-02-10
RU2009149175A (ru) 2011-07-10
PE20090317A1 (es) 2009-04-24
CL2008001549A1 (es) 2009-09-25
EP2148890A1 (fr) 2010-02-03
CN101679530B (zh) 2012-07-04
CA2682587C (fr) 2013-05-14
US8263577B2 (en) 2012-09-11
EP2148890B1 (fr) 2015-08-19
TN2009000443A1 (en) 2011-03-31
US20100305063A1 (en) 2010-12-02
CO6241161A2 (es) 2011-01-20
NZ581487A (en) 2012-04-27
TW200900055A (en) 2009-01-01
CA2682587A1 (fr) 2008-12-04

Similar Documents

Publication Publication Date Title
MA31456B1 (fr) Complexes de fer et de derives d'hydrates de carbone solubles dans l'eau, leur fabrication et medicaments les contenant
JOP20180046B1 (ar) متراكبات قابلة للذوبان في الماء من حديد وكربوهيدرات، إنتاجها وأدوية تحتوي عليها
Lin et al. Colorimetric acid phosphatase sensor based on MoO3 nanozyme
Deng et al. Visualization and quantification of neurochemicals with gold nanoparticles: opportunities and challenges
Cheng et al. A near-infrared fluorescent probe for visualizing transformation pathway of Cys/Hcy and H2S and its applications in living system
RU2006116252A (ru) Водные композиции, содержащие метронидазол
DE602006016938D1 (de) Funktionalisierte folien
CA2537920A1 (fr) Procedes et compositions de traitement de zones souterraines au moyen de compositions a dissociation differee
Ugru et al. Insight into the composition and surface corona reliant biological behaviour of quercetin engineered nanoparticles
ATE489077T1 (de) Schnell lösliche formulierung von nichtsteroidalen antiphlogistika
ATE443453T1 (de) Tomatenprodukte
DE60219609D1 (de) Prozess für die Vorbereitung von Piroxicam: Beta-Cyclodextrin Einschlusskomplexe
WO2008042499A3 (fr) Procédé permettant de préparer une gelée contenant de la pectine
Parada et al. Antibacterial activity and human cell cytotoxic of cobalt (III) complexes with 1, 10-phenanthroline and carbohydrate ligands
Shafie et al. Medicinal and Chemosensing Applications of Chitin-Based Materials: A Comprehensive Review
孟舒献 et al. Oxidizing cellulose to 2, 3-dialdehyde cellulose by sodium periodate
Mukherjee et al. A Kinetic and Mechanistic Study on Substitution of Aqua Ligands from cis-diaqua-bis-(bipyridyl)-ruthenium (II) Complex by Thiosemicarbazide in Aqueous Medium
Karageorgou et al. Green Synthesis and Characterization of Silver Nanoparticles with High Antibacterial Activity Using Cell Extracts of Cyanobacterium pseudanabaena/Limnothrix sp., 2022, 12, 2296
SE0401567D0 (sv) Concentration of beta-glucans
Ienco et al. COMPOSITION FOR ENZYME IMMUNOASSAY USING IMMUNOFLUORESCENCE AND USES THEREOF
MX2019013255A (es) Manufactura de compuestos de grafeno-naoparticulas de plata y plata-cobre y su uso como biosensores.
JP2023517850A (ja) 分解方法
TH69577A (th) สารเชิงซ้อนของเหล็กกับคาร์โบไฮเดรตในลักษณะเป็นน้ำการผลิตและผลิตภัณฑ์ยาที่มีสารนี้เป็นส่วนประกอบ
Sasaki et al. Nano sensory device utilizing intermolecular communication on lipid membrane
MD3047B1 (en) Tablet with iodine content